{"id":446409,"title":"Qualifying notice amendment for Lumakras (274523) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T11:52:31.949000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-amendment-lumakras-274523.html?wbdisable=false","snippet":"Qualifying notice amendment for Lumakras (274523) Pharmaceutical Drugs Directorate Holland Cross, Tower \"B\" 6th Floor, 1600 Scott Street Address Locator #3106B Ottawa ON K1A 0K9 Dossier identifier (ID): HC6-024-e230960 Control number: 274523 Amgen Canada Inc. c/o [name of…","rawSnapshotUrl":"/api/snapshots/raw/446409","browseUrl":"https://replay.healtharchive.ca/job-6/20260103115231/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-amendment-lumakras-274523.html?wbdisable=false#ha_snapshot=446409","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}